Noninvasix

Improving the neurological outcomes of premature babies with non-invasive brain oxygenation monitoring.

  • Stage Product In Development
  • Industry Medical Devices and Equipment
  • Location Houston, TX, US
  • Currency USD
  • Founded June 2007
  • Employees 2
  • Incorporation Type C-corp
  • Website noninvasix.com

Company Summary

To reduce the incidence of neonatal mortality and morbidity, Noninvasix is developing a patient monitor to directly, accurately, and noninvasively measure brain oxygenation in preterm babies in the NICU. Early detection of inadequate brain oxygenation will allow neonatologists to intervene before cerebral function is permanently compromised.

Team

  • Donald S Prough
    Clinical Vice President

    Donald Prough, M.D. has over 30 years experience in anesthesiology and critical care development and over 20 years experience in development and critical testing of systems for noninvasive monitoring. Dr. Prough is currently the Assistant Clinical Director of the Center for Biomedical Engineering and Rebecca Terry White Distinguished Chair and Professor of Anesthesiology at UTMB.

  • Graham Randall
    CEO

    Dr. Randall is a biotech entrepreneur with cross-industry experience in medical devices and Silicon Valley startups. He has successfully launched over a dozen products and his expertise includes R&D, product development, project management, professional services, software architecture, quantitative analysis, and problem solving.

  • David Giarracco
    CEO

Previous Investors

  • University of Texas Medical Branch
    Unconfirmed
    Texas Emerging Technology Fund
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free